• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶束在眼部给药中的新兴潜力。

Emerging potential of niosomes in ocular delivery.

机构信息

Pharmaceutics Research Projects Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya , Sagar, India.

Department of Materials Engineering, Indian Institute of Science , Bangalore, India.

出版信息

Expert Opin Drug Deliv. 2021 Jan;18(1):55-71. doi: 10.1080/17425247.2020.1822322. Epub 2020 Sep 23.

DOI:10.1080/17425247.2020.1822322
PMID:32903034
Abstract

INTRODUCTION

Niosomes have recently grabbed attention as one of the best tools for various site-specific drug delivery systems, including ophthalmic drug delivery. Surfactants (nonionic; tweens and spans) of different HLB values and cholesterol are the fundamental components for these formulations. It is an alternative controlled ocular drug delivery system to liposomes to overcome the problems associated with sterilization, large-scale production, and stability. It also enhances the adhesion or retention ability of drug at the ocular site. Hydrophilic or lipophilic or amphoteric drugs can be easily encapsulated in niosomes. Besides, niosomes are a leading vesicular system compatible with most of the drugs for site-specific delivery.

AREAS COVERED

This article reveals challenges and barriers for ocular drug delivery, various transporters and receptors present in the ocular region for the transportation of therapeutics as well as nutrients, and various method of preparations, loading methods and application potential of niosomes in ocular drug delivery.

EXPERT OPINION

Niosomes, a vesicular system offers numerous advantages and applicability because of its good stability, non-immunogenicity, permeation potential, and controlled release ability etc. This drug delivery system has been efficiently used in the treatment of many ocular diseases.

摘要

简介

作为各种定位药物输送系统(包括眼部药物输送系统)的最佳工具之一,近年来,毫微囊受到了关注。不同 HLB 值和胆固醇的表面活性剂(非离子型;吐温类和司盘类)是这些制剂的基本组成部分。它是一种替代脂质体的控释眼部药物输送系统,可克服与灭菌、大规模生产和稳定性相关的问题。它还增强了药物在眼部的黏附或保留能力。亲水性、亲脂性或两性药物都可以很容易地包封在毫微囊中。此外,毫微囊是一种与大多数药物相容的主导囊泡系统,适用于定位输送。

涵盖领域

本文揭示了眼部药物输送的挑战和障碍,眼部区域中存在的各种转运体和受体用于治疗药物和营养物质的运输,以及毫微囊在眼部药物输送中的各种制备方法、载药方法和应用潜力。

专家意见

毫微囊作为一种囊泡系统,由于其良好的稳定性、非免疫原性、渗透潜力和控释能力等优点,具有广泛的适用性。这种药物输送系统已被有效地用于治疗许多眼部疾病。

相似文献

1
Emerging potential of niosomes in ocular delivery.胶束在眼部给药中的新兴潜力。
Expert Opin Drug Deliv. 2021 Jan;18(1):55-71. doi: 10.1080/17425247.2020.1822322. Epub 2020 Sep 23.
2
Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.近年来非离子表面活性剂囊泡(niosomes)的研究进展:制备、表征、药物和化妆品应用。
Eur J Pharm Biopharm. 2019 Nov;144:18-39. doi: 10.1016/j.ejpb.2019.08.015. Epub 2019 Aug 22.
3
The Impact of Surfactant Composition and Surface Charge of Niosomes on the Oral Absorption of Repaglinide as a BCS II Model Drug.胶束的表面活性剂组成和表面电荷对作为 BCS Ⅱ类模型药物的瑞格列奈口服吸收的影响。
Int J Nanomedicine. 2020 Nov 11;15:8767-8781. doi: 10.2147/IJN.S261932. eCollection 2020.
4
Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.盐酸多西环素脂质体的设计及体外评价作为一种潜在的眼部给药系统。
Int J Pharm. 2019 Aug 15;567:118431. doi: 10.1016/j.ijpharm.2019.06.022. Epub 2019 Jun 14.
5
Niosomes as a propitious carrier for topical drug delivery.脂质体作为局部递药的有利载体。
Expert Opin Drug Deliv. 2013 Feb;10(2):261-72. doi: 10.1517/17425247.2013.746310. Epub 2012 Dec 19.
6
Niosomes in sustained and targeted drug delivery: some recent advances.用于持续和靶向给药的脂质体:一些最新进展。
J Drug Target. 2009 Nov;17(9):671-89. doi: 10.3109/10611860903079454.
7
Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.专业化尼莫辛药物传递的最新进展:制造、特性描述和药物传递应用。
Int J Mol Sci. 2022 Aug 26;23(17):9668. doi: 10.3390/ijms23179668.
8
Methods for preparation of niosomes: A focus on thin-film hydration method.制备非离子表面活性剂囊泡的方法:聚焦薄膜水化法。
Methods. 2022 Mar;199:9-15. doi: 10.1016/j.ymeth.2021.05.004. Epub 2021 May 14.
9
A new approach for the evaluation of niosomes as effective transdermal drug delivery systems.一种评估尼奥斯omes 作为有效经皮药物传递系统的新方法。
Eur J Pharm Biopharm. 2011 Sep;79(1):28-35. doi: 10.1016/j.ejpb.2011.01.020. Epub 2011 Feb 12.
10
A Comprehensive Review on Niosomes as a Tool for Advanced Drug Delivery.载药囊泡作为高级药物传递工具的全面综述。
Pharm Nanotechnol. 2024;12(3):206-228. doi: 10.2174/2211738511666230726154557.

引用本文的文献

1
Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases.基于纳米技术的眼部给药系统:眼部疾病治疗的综合综述
Discov Nano. 2025 May 3;20(1):75. doi: 10.1186/s11671-025-04234-6.
2
The niosomal nelarabine as a promising nano combination for retinoblastoma treatment: an study-experimental research.作为视网膜母细胞瘤治疗有前景的纳米组合的尼洛替尼脂质体:一项实验性研究。 (注:原文中的“niosomal nelarabine”疑似有误,可能是“liposomal nelarabine”,即脂质体阿糖胞苷,我按纠正后的进行意译,若原文无误请按实际情况调整)
Ann Med Surg (Lond). 2025 Jan 9;87(1):121-129. doi: 10.1097/MS9.0000000000002821. eCollection 2025 Jan.
3
Bioadhesive hybrid system of niosomes and pH sensitive gel for itraconazole ocular delivery: Dual approach for efficient treatment of fungal infections.
用于伊曲康唑眼部给药的脂质体与pH敏感凝胶的生物粘附混合系统:高效治疗真菌感染的双重方法
Saudi Pharm J. 2024 Dec;32(12):102208. doi: 10.1016/j.jsps.2024.102208. Epub 2024 Nov 22.
4
Functional Evaluation of Niosomes Utilizing Surfactants in Nanomedicine Applications.利用纳米医学应用中的表面活性剂的尼欧索米的功能评估。
Int J Nanomedicine. 2024 Oct 10;19:10283-10305. doi: 10.2147/IJN.S480639. eCollection 2024.
5
Niosomes as a Promising Therapeutic Approach against Colorectal Cancer: A Focus on the Delivery of Chemotherapeutics and Natural Products.载药囊泡作为治疗结直肠癌的一种有前途的方法:聚焦于化疗药物和天然产物的递送。
Curr Pharm Des. 2024;30(21):1659-1666. doi: 10.2174/0113816128303645240429052835.
6
Steroidal nanoformulations for the treatment of uveitis: potential, promises and future perspectives.用于治疗葡萄膜炎的甾体纳米制剂:潜力、前景与未来展望。
Int Ophthalmol. 2024 Feb 12;44(1):58. doi: 10.1007/s10792-024-03000-4.
7
Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment.研制载有溴莫尼定的尼欧索姆隐形眼镜用于延长释放及有望成为治疗青光眼的新传递系统。
Daru. 2024 Jun;32(1):161-175. doi: 10.1007/s40199-023-00500-z. Epub 2023 Dec 29.
8
5-Fluorouracil-Loaded Hyaluronic Acid-Coated Niosomal Vesicles: Fabrication and Ex Vivo Evaluation for Skin Drug Delivery.负载5-氟尿嘧啶的透明质酸包被非离子表面活性剂囊泡:用于皮肤给药的制备及体外评价
ACS Omega. 2023 Nov 27;8(48):45405-45413. doi: 10.1021/acsomega.3c04457. eCollection 2023 Dec 5.
9
Ophthalmic Bimatoprost-Loaded Niosomal In Situ Gel: Preparation, Optimization, and In Vivo Pharmacodynamics Study.载有比马前列素的眼用非离子表面活性剂囊泡原位凝胶:制备、优化及体内药效学研究
Polymers (Basel). 2023 Nov 6;15(21):4336. doi: 10.3390/polym15214336.
10
Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.纳米技术介导的草药纳米系统在眼科药物中的应用。
Pharm Nanotechnol. 2024;12(3):229-250. doi: 10.2174/2211738511666230816090046.